Prognostic value of inflammatory markers in predicting recurrence-free survival in gastrointestinal stromal tumor patients: A nomogram-based approach

Table 1 Patient characteristics, n (%)

Variable	n	mean ± SD
Age (years)		58 ± 12.836
BMI		22.10 ± 3.692
Sex
Male	48 (38.70)
Female	76 (61.30)
Anatomic site of GIST
Gastric tumors	76 (61.30)
Non-gastric tumors	48 (38.70)
Tumor size (cm)
< 5	66 (53.23)
≥ 5	58 (46.77)
Targeted therapy
Yes	31 (25)
No	93 (75)
5-years RFS	93 (75)

BMI: Body mass index; GIST: Gastrointestinal stromal tumor; RFS: Recurrence-free survival.